Gujarat Themis Biosyn informs about error in transcript of call

20 Nov 2021 Evaluate

With reference to its intimation bearing ref GTBL: CS: BSE-CORR/2021-22 dated 18th November, 2021. Gujarat Themis Biosyn has informed that the first page of transcript in the management details Company name- Gujarat Themis Biosyn has been inadvertently appeared after the name of Tushar Dalal and Sangameshwar Iyer and Compliance Officer after Sangameshwar Iyer. It has rectified the typographical error and no change except the first page. Hence, the company enclosed the Earnings Call Transcript pertaining to 02 and H1 of FY22 Financial Results of the Company with the rectified first page. The aforesaid information is also being made available on the website of the Company at www.gtbl.in.

The above information is a part of company’s filings submitted to BSE.

Guj. Themis Biosyn Share Price

391.30 1.15 (0.29%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×